Earth Science Tech , Inc. (OTCMKTS:ETST) Files An 8-K Other Events

Earth Science Tech , Inc. (OTCMKTS:ETST) Files An 8-K Other Events
Item 8.01 Other Events

On March 4, 2020, the U.S. Securities and Exchange Commission (the “SEC”) issued an order (Release No. 34-88318) under Section 36 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), granting exemptions from specified provisions of the Exchange Act and certain rules thereunder. On March 25, 2020, the order was modified and superseded by a new SEC order (Release No. 34-88465) that provides conditional relief to public companies with respect to their filing requirements as a result of the recent coronavirus (“COVID-19”) outbreak (the “SEC Order”).

Earth Science Tech, Inc.. (the “Company”, “ETST”, “we” or “our”) will be relying on the SEC Order related to the timing of the filing of its Annual Report on Form 10-K for the March 31, 2020 Fiscal Year End (the “FYE”) due to circumstances related to the COVID-19 outbreak.

As a result of COVID-19, ETST has been following the recommendations of health authorities to minimize exposure risk, and limited access to the Company’s facilities resulting in limited support from its staff, and professional advisors who have also taken similar precautions. This has impacted the normal interactions and collaborations among ETST’s accounting, financial reporting personnel and legal counsel involved with the completion of the quarterly review and preparation of the Annual Report.

Although the Company can provide no assurance, ETST does plan to file the Annual Report on or before July 15, 2020, but, in any event, no later than August 13, 2020, which is 45 days from the Annual Report’s original filing deadline of June 29, 2020. If the Quarterly Report is filed by August 13, 2020, the filing will be deemed timely by the SEC.

In light of the current COVID-19 pandemic, the Company will be including the following Risk Factor in its Report.

A pandemic, epidemic or outbreak of an infectious disease, such as COVID-19, may materially and adversely affect our business and operations, and our ability to complete financial reports to enable us to comply with our reporting obligation under the Exchange Act.

 

The occurrence of a pandemic, epidemic, or outbreak of an infectious disease including the recent outbreak of respiratory illness caused by a novel coronavirus (COVID-19), and efforts to contain the spread of the such a pandemic, epidemic, or outbreak, which includes social distancing, travel bans and quarantine, could limited access to our facilities, management, support staff and professional advisors. These, in turn, could impact our operations, financial condition, development work and demand for our products and services, and our overall ability to react timely to mitigate the impact of such an event. These factors could substantially hamper our efforts to provide our investors with timely information and comply with our filing obligations with the Securities and Exchange Commission.


About Earth Science Tech , Inc. (OTCMKTS:ETST)

Story continues below

Earth Science Tech, Inc. is a biotechnology company. The Company is focused on nutraceuticals and bioceuticals for use in various industries, such as health, wellness, nutritional supplements, cosmetic and alternative medicine to manage illnesses and the quality of life for consumers around the world. The Company sells its products through its retail store located in Coral Gables, Florida, and through the Internet. The Company is focused on delivering nutritional and dietary supplements that help with treating symptoms, such as chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and aging. This may include products, such as vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products. These products will be in various formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs.

An ad to help with our costs